Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. Must try harder: do the Holyrood 2026 manifestos meet our tests?

  2. An energy smart meter sits on a countertop. It reads electricity: £61.71, gas: £148

    Flex factor: How government can keep network costs on bills down

    Government must strike a better balance between bringing down energy bills now and building a system fit for the future.

  3. Acceleration is not a strategy: A framework for directing AI towards public value before it's too late

    The politics of artificial intelligence is set to drastically change in 2026 as recent technical breakthroughs get implemented across the economy.